Exact Mass: 744.0314

Exact Mass Matches: 744.0314

Found 13 metabolites which its exact mass value is equals to given mass value 744.0314, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Nicotinate adenine dinucleotide phosphate

1-(5-{[({[5-(6-amino-9H-purin-9-yl)-3-hydroxy-4-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl phosphono)oxy]methyl}-3,4-dihydroxyoxolan-2-yl)-3-carboxy-1lambda5-pyridin-1-ylium

C21H27N6O18P3 (744.0595)


   

Nicotinic acid adenine dinucleotide

Nicotinic acid adenine dinucleotide

C21H27N6O18P3 (744.0595)


   

Nicotinic acid adenine dinucleotide phosphate sodium salt

Nicotinic acid adenine dinucleotide phosphate sodium salt

C21H27N6O18P3 (744.0595)


   
   

Nicotinic acid adenine dinucleotide phosphate

Nicotinic acid adenine dinucleotide phosphate

C21H27N6O18P3 (744.0595)


   

beta-NAADP

1-[(2R,3R,4S,5R)-5-[[[[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxymethyl]-3,4-dihydroxyoxolan-2-yl]pyridin-1-ium-3-carboxylic acid

C21H27N6O18P3 (744.0595)


   
   

(TETRACARBOXYPHTHALOCYANINATO)IRON(II)

(TETRACARBOXYPHTHALOCYANINATO)IRON(II)

C36H16FeN8O8 (744.044)


   

Nicotinate adenine dinucleotide phosphate

1-(5-{[({[5-(6-amino-9H-purin-9-yl)-3-hydroxy-4-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl phosphono)oxy]methyl}-3,4-dihydroxyoxolan-2-yl)-3-carboxy-1lambda5-pyridin-1-ylium

C21H27N6O18P3 (744.0595)


   

Teflaro

Teflaro

C24H25N8O10PS4 (744.0314)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methyl [[(3R,4S,5S)-5-(3-carboxypyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphate

[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methyl [[(3R,4S,5S)-5-(3-carboxypyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphate

C21H27N6O18P3 (744.0595)


   

Ceftaroline fosamil acetate

Ceftaroline fosamil acetate

C24H25N8O10PS4 (744.0314)


An acetate salt obtained by reaction of ceftaroline fosamil with one equivalent of acetic acid. A prodrug for ceftaroline, used for the treatment of adults with acute bacterial skin and skin structure infections.